Chris Johnson is the Managing Partner of Altheros Capital, a middle market investment and advisory firm. Prior to Altheros Capital, Mr. Johnson was the Chief Investment Officer of three holding companies, where he was responsible for the investment strategy, acquisitions and portfolio company management.

Mr. Johnson gained operational experience as a revenue growth executive and strategist at industry leaders like Boston Scientific and Rhapsody, where he led in product innovation, general management, business development, and equity &  debt capital fundraising. Mr. Johnson began his career as an investment banking analyst at Donaldson, Lufkin & Jenrette. He has executed over $6 billion of middle market mergers & acquisitions and financing transactions.

At media holding company Fluid Media, he worked with a small team to complete the LBO rollup of the US, Latin American, and European in-store media industries. The leveraged buyouts of the industry leaders, including Muzak and DMX, helped transform Fluid Media from a private entity with $4 million in revenues into Mood Media, the publicly traded, global in-store media #1 market leader in over 40 countries with $500 million in revenues and $120 million in EBITDA. In addition to deal sourcing and execution, his responsibilities as an executive at the holding companies included creating, staffing, and leading subsidiary companies to target specific market opportunities and working with the management teams of acquired companies to boost revenue growth and to rationalize operations.

In his 15 years of operating experience in Fortune 500, middle market, and early stage environments, he has collaborated with engineers to create new products, led 18 product launches, invented and received a US patent for an algorithm that made medical devices more specific in their application of therapy, and driven over $800 million in revenue growth. He has a BA in economics from Columbia University and an MBA from the Harvard Business School.